Literature DB >> 27334808

Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the Disease.

Bing Han1, Melanie Newbould2, Gauri Batra2, Edmund Cheesman2, Ross J Craigie3, Zainab Mohamed4, Lindsey Rigby5, Raja Padidela5, Mars Skae5, Aleksandr Mironov1, Tobias Starborg1, Karl E Kadler1, Karen E Cosgrove6, Indraneel Banerjee5, Mark J Dunne6.   

Abstract

OBJECTIVES: To quantify islet cell nucleomegaly in controls and tissues obtained from patients with congenital hyperinsulinism in infancy (CHI) and to examine the association of nucleomegaly with proliferation.
METHODS: High-content analysis of histologic sections and serial block-face scanning electron microscopy were used to quantify nucleomegaly.
RESULTS: Enlarged islet cell nuclear areas were 4.3-fold larger than unaffected nuclei, and the mean nuclear volume increased to approximately threefold. Nucleomegaly was a normal feature of pediatric islets and detected in the normal regions of the pancreas from patients with focal CHI. The incidence of nucleomegaly was highest in diffuse CHI (CHI-D), with more than 45% of islets containing two or more affected cells. While in CHI-D nucleomegaly was negatively correlated with cell proliferation, in all other cases, there was a positive correlation.
CONCLUSIONS: Increased incidence of nucleomegaly is pathognomonic for CHI-D, but these cells are nonproliferative, suggesting a novel role in the pathobiology of this condition. © American Society for Clinical Pathology, 2016.

Entities:  

Keywords:  Congenital hyperinsulinism; Hyperplasia; Hypoglycemia; Insulin; Islet; Nucleomegaly; Pancreas; Serial block-face scanning electron microscopy; β cell

Mesh:

Year:  2016        PMID: 27334808      PMCID: PMC4922485          DOI: 10.1093/ajcp/aqw075

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  46 in total

1.  Focal or diffuse lesions in persistent hyperinsulinemic hypoglycemia of infancy: concerns about interpretation of intraoperative frozen sections.

Authors:  V V Smith; M Malone; R A Risdon
Journal:  Pediatr Dev Pathol       Date:  2001 Mar-Apr

2.  Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy.

Authors:  P de Lonlay; J C Fournet; J Rahier; M S Gross-Morand; F Poggi-Travert; V Foussier; J P Bonnefont; M C Brusset; F Brunelle; J J Robert; C Nihoul-Fékété; J M Saudubray; C Junien
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Using transmission electron microscopy and 3View to determine collagen fibril size and three-dimensional organization.

Authors:  Tobias Starborg; Nicholas S Kalson; Yinhui Lu; Aleksandr Mironov; Timothy F Cootes; David F Holmes; Karl E Kadler
Journal:  Nat Protoc       Date:  2013-06-27       Impact factor: 13.491

4.  Congenital hyperinsulinism in Chinese patients: 5-yr treatment outcome of 95 clinical cases with genetic analysis of 55 cases.

Authors:  Chunxiu Gong; Shuyue Huang; Chang Su; Zhan Qi; Fang Liu; Di Wu; Bingyan Cao; Yi Gu; Wenjin Li; Xuejun Liang; Min Liu
Journal:  Pediatr Diabetes       Date:  2015-02-02       Impact factor: 4.866

5.  The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism.

Authors:  I Banerjee; M Skae; S E Flanagan; L Rigby; L Patel; M Didi; J Blair; S Ehtisham; S Ellard; K E Cosgrove; M J Dunne; P E Clayton
Journal:  Eur J Endocrinol       Date:  2011-03-04       Impact factor: 6.664

6.  Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist's role.

Authors:  J Rahier; C Sempoux; J C Fournet; F Poggi; F Brunelle; C Nihoul-Fekete; J M Saudubray; F Jaubert
Journal:  Histopathology       Date:  1998-01       Impact factor: 5.087

7.  Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.

Authors:  Olga T Hardy; Miguel Hernandez-Pampaloni; Janet R Saffer; Joshua S Scheuermann; Linda M Ernst; Richard Freifelder; Hongming Zhuang; Courtney MacMullen; Susan Becker; N Scott Adzick; Chaitanya Divgi; Abass Alavi; Charles A Stanley
Journal:  J Clin Endocrinol Metab       Date:  2007-09-25       Impact factor: 5.958

8.  Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.

Authors:  Winfried Barthlen; Oliver Blankenstein; Harald Mau; Martin Koch; Claudia Höhne; Wolfgang Mohnike; Traugott Eberhard; Frank Fuechtner; Bettina Lorenz-Depiereux; Klaus Mohnike
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

9.  Lead aspartate, an en bloc contrast stain particularly useful for ultrastructural enzymology.

Authors:  J Walton
Journal:  J Histochem Cytochem       Date:  1979-10       Impact factor: 2.479

Review 10.  Congenital hyperinsulinism: current trends in diagnosis and therapy.

Authors:  Jean-Baptiste Arnoux; Virginie Verkarre; Cécile Saint-Martin; Françoise Montravers; Anaïs Brassier; Vassili Valayannopoulos; Francis Brunelle; Jean-Christophe Fournet; Jean-Jacques Robert; Yves Aigrain; Christine Bellanné-Chantelot; Pascale de Lonlay
Journal:  Orphanet J Rare Dis       Date:  2011-10-03       Impact factor: 4.123

View more
  14 in total

1.  Functional and Metabolomic Consequences of KATP Channel Inactivation in Human Islets.

Authors:  Changhong Li; Amanda M Ackermann; Kara E Boodhansingh; Tricia R Bhatti; Chengyang Liu; Jonathan Schug; Nicolai Doliba; Bing Han; Karen E Cosgrove; Indraneel Banerjee; Franz M Matschinsky; Itzhak Nissim; Klaus H Kaestner; Ali Naji; N Scott Adzick; Mark J Dunne; Charles A Stanley; Diva D De León
Journal:  Diabetes       Date:  2017-04-25       Impact factor: 9.461

Review 2.  Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties.

Authors:  Arianna Maiorana; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2017-06-27       Impact factor: 4.982

3.  SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism.

Authors:  Väinö Lithovius; Jonna Saarimäki-Vire; Diego Balboa; Hazem Ibrahim; Hossam Montaser; Tom Barsby; Timo Otonkoski
Journal:  Diabetologia       Date:  2021-01-06       Impact factor: 10.122

4.  Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time.

Authors:  Maria Salomon-Estebanez; Sarah E Flanagan; Sian Ellard; Lindsey Rigby; Louise Bowden; Zainab Mohamed; Jacqueline Nicholson; Mars Skae; Caroline Hall; Ross Craigie; Raja Padidela; Nuala Murphy; Tabitha Randell; Karen E Cosgrove; Mark J Dunne; Indraneel Banerjee
Journal:  Orphanet J Rare Dis       Date:  2016-12-01       Impact factor: 4.123

Review 5.  Congenital Hyperinsulinism: Diagnosis and Treatment Update.

Authors:  Hüseyin Demirbilek; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27

6.  Atypical Forms of Congenital Hyperinsulinism in Infancy Are Associated With Mosaic Patterns of Immature Islet Cells.

Authors:  Bing Han; Zainab Mohamed; Maria Salomon Estebanez; Ross J Craigie; Melanie Newbould; Edmund Cheesman; Raja Padidela; Mars Skae; Matthew Johnson; Sarah Flanagan; Sian Ellard; Karen E Cosgrove; Indraneel Banerjee; Mark J Dunne
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

Review 7.  Diagnosis and treatment of hyperinsulinaemic hypoglycaemia and its implications for paediatric endocrinology.

Authors:  Huseyin Demirbilek; Sofia A Rahman; Gonul Gulal Buyukyilmaz; Khalid Hussain
Journal:  Int J Pediatr Endocrinol       Date:  2017-08-29

8.  Clinical Diversity in Focal Congenital Hyperinsulinism in Infancy Correlates With Histological Heterogeneity of Islet Cell Lesions.

Authors:  Ross J Craigie; Maria Salomon-Estebanez; Daphne Yau; Bing Han; Walaa Mal; Melanie Newbould; Edmund Cheesman; Stefania Bitetti; Zainab Mohamed; Rakesh Sajjan; Raja Padidela; Mars Skae; Sarah Flanagan; Sian Ellard; Karen E Cosgrove; Indraneel Banerjee; Mark J Dunne
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-17       Impact factor: 5.555

Review 9.  Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.

Authors:  I Banerjee; M Salomon-Estebanez; P Shah; J Nicholson; K E Cosgrove; M J Dunne
Journal:  Diabet Med       Date:  2018-10-08       Impact factor: 4.359

10.  Morphoproteomics and biomedical analytics coincide with clinical outcomes in supporting a constant but variable role for the mTOR pathway in the biology of congenital hyperinsulinism of infancy.

Authors:  Robert E Brown; Senthil Senniappan; Khalid Hussain; Mary F McGuire
Journal:  Orphanet J Rare Dis       Date:  2017-12-16       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.